IL129607A0 - Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation - Google Patents

Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation

Info

Publication number
IL129607A0
IL129607A0 IL12960797A IL12960797A IL129607A0 IL 129607 A0 IL129607 A0 IL 129607A0 IL 12960797 A IL12960797 A IL 12960797A IL 12960797 A IL12960797 A IL 12960797A IL 129607 A0 IL129607 A0 IL 129607A0
Authority
IL
Israel
Prior art keywords
quinuprisitine
dalfopristine
preparation
pharmaceutical compositions
compositions based
Prior art date
Application number
IL12960797A
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL129607A0 publication Critical patent/IL129607A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
IL12960797A 1996-11-19 1997-11-14 Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation IL129607A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (en) 1996-11-19 1996-11-19 STABILIZED PHARMACEUTICAL COMPOSITIONS BASED ON QUINUPRISTINE AND DALFOPRISTINE AND THEIR PREPARATION
PCT/FR1997/002047 WO1998022107A1 (en) 1996-11-19 1997-11-14 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation

Publications (1)

Publication Number Publication Date
IL129607A0 true IL129607A0 (en) 2000-02-29

Family

ID=9497744

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12960797A IL129607A0 (en) 1996-11-19 1997-11-14 Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation
IL129607A IL129607A (en) 1996-11-19 1999-04-26 Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and process for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL129607A IL129607A (en) 1996-11-19 1999-04-26 Stabilized pharmaceutical compositions based on quinupristine and on dalfopristine and process for their preparation

Country Status (45)

Country Link
US (1) US5994338A (en)
EP (1) EP0949923B1 (en)
JP (1) JP4278115B2 (en)
KR (1) KR100530836B1 (en)
CN (1) CN1146417C (en)
AP (1) AP998A (en)
AR (1) AR008695A1 (en)
AT (1) ATE223217T1 (en)
AU (1) AU740291B2 (en)
BG (1) BG63621B1 (en)
BR (1) BR9713087A (en)
CA (1) CA2271095C (en)
CO (1) CO4910113A1 (en)
CZ (1) CZ299913B6 (en)
DE (1) DE69715247T2 (en)
DK (1) DK0949923T3 (en)
DZ (1) DZ2349A1 (en)
EA (1) EA002025B1 (en)
EE (1) EE03668B1 (en)
ES (1) ES2179375T3 (en)
FR (1) FR2755857B1 (en)
HK (1) HK1022832A1 (en)
HR (1) HRP970615B1 (en)
HU (1) HUP9904327A3 (en)
IL (2) IL129607A0 (en)
IN (1) IN187038B (en)
JO (1) JO1992B1 (en)
MA (1) MA26448A1 (en)
MY (1) MY123805A (en)
NO (1) NO992399D0 (en)
NZ (1) NZ334949A (en)
OA (1) OA11047A (en)
PE (1) PE13999A1 (en)
PL (1) PL190164B1 (en)
PT (1) PT949923E (en)
RS (1) RS49608B (en)
SA (1) SA97180645B1 (en)
SK (1) SK284311B6 (en)
TN (1) TNSN97184A1 (en)
TR (1) TR199901096T2 (en)
TW (1) TW474816B (en)
UA (1) UA59376C2 (en)
UY (1) UY24780A1 (en)
WO (1) WO1998022107A1 (en)
ZA (1) ZA9710435B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (en) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITIONS BASED ON DALFOPRISTINE AND QUINUPRISTINE AND THEIR PREPARATION
ATE322280T1 (en) 1998-09-25 2006-04-15 Cubist Pharm Inc USE OF DAPTOMYCIN
ATE294571T1 (en) * 1999-03-03 2005-05-15 Lilly Co Eli ECHINOCANDIN PHARMACEUTICAL COMPOSITIONS
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (en) * 2000-08-03 2003-03-21 Aventis Pharma Sa DALFOPRISTINE / QUINUPRISTINE ASSOCIATIONS WITH CEFPIROME
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (en) * 1983-07-13 1985-10-25 Rhone Poulenc Sante NOVEL SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2576022B1 (en) * 1985-01-11 1987-09-11 Rhone Poulenc Sante NOVEL DERIVATIVES OF PRISTINAMYCIN II B, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2599036B1 (en) * 1986-05-22 1988-09-09 Rhone Poulenc Sante NOVEL SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Also Published As

Publication number Publication date
EP0949923B1 (en) 2002-09-04
PE13999A1 (en) 1999-05-05
UY24780A1 (en) 2001-08-27
WO1998022107A1 (en) 1998-05-28
NO992399L (en) 1999-05-19
SK284311B6 (en) 2005-01-03
CZ299913B6 (en) 2008-12-29
US5994338A (en) 1999-11-30
CN1233959A (en) 1999-11-03
HRP970615A2 (en) 1998-08-31
HK1022832A1 (en) 2000-08-25
DZ2349A1 (en) 2002-12-28
DE69715247D1 (en) 2002-10-10
PT949923E (en) 2003-01-31
JP4278115B2 (en) 2009-06-10
FR2755857B1 (en) 1998-12-24
EP0949923A1 (en) 1999-10-20
CO4910113A1 (en) 2000-04-24
FR2755857A1 (en) 1998-05-22
NO992399D0 (en) 1999-05-19
RS49608B (en) 2007-06-04
ES2179375T3 (en) 2003-01-16
HRP970615B1 (en) 2002-12-31
CZ174899A3 (en) 1999-08-11
AP998A (en) 2001-08-09
CA2271095C (en) 2004-08-03
SK66099A3 (en) 2000-01-18
EE03668B1 (en) 2002-04-15
KR100530836B1 (en) 2005-11-23
IL129607A (en) 2006-08-20
SA97180645B1 (en) 2005-12-12
UA59376C2 (en) 2003-09-15
TW474816B (en) 2002-02-01
EA002025B1 (en) 2001-12-24
YU22499A (en) 2002-03-18
TNSN97184A1 (en) 2005-03-15
AU5125698A (en) 1998-06-10
NZ334949A (en) 2000-12-22
AU740291B2 (en) 2001-11-01
PL190164B1 (en) 2005-11-30
EE9900127A (en) 1999-12-15
EA199900479A1 (en) 2000-02-28
HUP9904327A2 (en) 2000-06-28
HUP9904327A3 (en) 2002-03-28
ZA9710435B (en) 1998-06-10
MY123805A (en) 2006-06-30
CN1146417C (en) 2004-04-21
OA11047A (en) 2003-03-07
AR008695A1 (en) 2000-02-09
IN187038B (en) 2001-12-29
ATE223217T1 (en) 2002-09-15
BG103412A (en) 2000-06-30
BG63621B1 (en) 2002-07-31
DK0949923T3 (en) 2002-12-23
BR9713087A (en) 2000-03-28
KR20000053343A (en) 2000-08-25
JO1992B1 (en) 1999-05-15
MA26448A1 (en) 2004-12-20
TR199901096T2 (en) 1999-07-21
JP2001504475A (en) 2001-04-03
DE69715247T2 (en) 2003-04-30
CA2271095A1 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
NZ314184A (en) Substituted quinazoline derivatives and pharmaceutical compositions
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
EG24118A (en) Pharmaceutical compositions
HUP9900424A2 (en) Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
GB9616672D0 (en) Pharmaceutical compositions
HUP0101701A3 (en) Substituted betha-alanines and pharmaceutical compositions comprising them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
GB9610359D0 (en) Pharmaceutical compositions
IL117623A0 (en) Maltitol compositions and its preparation
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
HK1040165A1 (en) Nutritional and pharmaceutical compositions
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA9811470B (en) Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation
IL129607A0 (en) Stabilized pharmaceutical compositions based on quinuprisitine and on dalfopristine and their preparation
ZA979726B (en) Pharmaceutical compositions
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
GB9613457D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
GB9618376D0 (en) Pharmaceutical compositions
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
IL120469A0 (en) 1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees